Shalby Ltd. Stock Falls to 52-Week Low of Rs.144.55 Amidst Continued Downtrend

Recent Price Movement and Market Context

On 5 Mar 2026, Shalby Ltd. closed at Rs.144.55, down 1.32% on the day and underperforming its hospital sector peers by 1.01%. The stock has been on a losing streak for five consecutive sessions, cumulatively falling 7.12% over this period. Intraday, it touched a high of Rs.150.3, but was unable to sustain gains. Notably, Shalby is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling persistent bearish momentum.

In contrast, the broader market showed resilience with the Sensex opening 414.29 points higher and trading at 79,606.19, up 0.62%. The NIFTY CPSE index even hit a new 52-week high, underscoring the divergence between Shalby’s performance and the overall market trend. While the Sensex remains below its 50-day moving average, the 50DMA is positioned above the 200DMA, indicating a cautiously optimistic medium-term market outlook. Mega-cap stocks led the gains, further highlighting Shalby’s relative weakness.

Financial Performance and Valuation Metrics

Shalby Ltd.’s financial results have contributed to the subdued market sentiment. The company reported flat results for the quarter ended December 2025, with Profit Before Tax (PBT) falling sharply by 71.14% to Rs.2.00 crore. This sharp contraction in profitability has weighed heavily on investor confidence.

Return on Capital Employed (ROCE) for the half-year stood at a low 6.10%, reflecting limited efficiency in generating returns from its capital base. Meanwhile, the debt-equity ratio rose to 0.53 times, the highest level recorded in recent periods, indicating a modest increase in leverage. Despite this, Shalby maintains a relatively strong ability to service its debt, with a Debt to EBITDA ratio of 1.18 times, suggesting manageable financial obligations in the near term.

From a valuation perspective, the stock is trading at a discount relative to its peers’ historical averages. The Enterprise Value to Capital Employed ratio is 1.4, which is considered very attractive. However, this valuation advantage has not translated into positive returns, as the stock has generated a negative 26.29% return over the past year, significantly lagging the Sensex’s 7.97% gain during the same period.

Long-Term Performance and Shareholding Patterns

Over the last three years, Shalby Ltd. has consistently underperformed the BSE500 index, with returns remaining below benchmark levels across multiple time frames including one year and three months. The stock’s 52-week high was Rs.274.5, indicating a steep decline of nearly 47.4% from that peak to the current low.

Domestic mutual funds hold a negligible stake in Shalby Ltd., with reported ownership at 0%. Given their capacity for detailed on-the-ground research, this absence of institutional interest may reflect reservations about the company’s current valuation or business prospects.

Growth and Profitability Trends

Despite recent setbacks, Shalby has demonstrated healthy long-term growth in net sales, which have increased at an annualised rate of 23.17%. Operating profit has also expanded at a compound annual growth rate of 25.38%, signalling underlying business expansion. However, profits have declined sharply by 76.2% over the past year, highlighting a disconnect between revenue growth and bottom-line performance.

The company’s ROCE of 5% is modest, and while the valuation metrics suggest an attractive entry point relative to peers, the persistent decline in profitability and share price has overshadowed these positives.

Summary of Key Metrics

As of the latest reporting period, Shalby Ltd. holds a Mojo Score of 40.0 and a Mojo Grade of Sell, downgraded from Hold on 1 Dec 2025. The company’s market capitalisation grade stands at 3, reflecting its mid-tier size within the hospital sector. The stock’s recent performance and financial indicators have contributed to this rating adjustment.

In summary, Shalby Ltd. has experienced a notable decline in its share price, culminating in a 52-week low of Rs.144.55. This movement is underpinned by subdued profitability, modest returns on capital, and limited institutional interest. While the company continues to grow its sales and operating profit on a long-term basis, the sharp contraction in net profits and persistent share price weakness remain key concerns for market participants.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →